Periphere, exsudative hämorrhagische Chorioretinopathie: Klinische und angiografische Befunde

Abstract

Peripheral exudative hemorrhagic chorioretinopathy should be considered in the differential diagnosis of vitreous haemorrhage and peripheral subretinal tumors in the elderly.

Regression of Serous Macular Detachment Due to Peripheral Exudative Hemorrhagic Chorioretinopathy following Intravitreal Bevacizumab

“…Clinical manifestations may vary significantly in appearance, often leading to misdiagnosis as a hemorrhagic retinal break, an inflammatory process, or even choroidal melanoma (1,2). Peripheral exudative hemorrhagic chorioretinopathy occasionally causes vision loss, most often due to posterior extension of subretinal fluid (SRf) and/ or hemorrhage, or by extension of peripheral hemorrhage into the vitreous (1,3,4). This condition occurs in elderly patients with systemic hypertension, diabetes, and arteriosclerosis (the same demographic as age-related macu-regression of serous macular detachment due to peripheral exudative hemorrhagic chorioretinopathy following intravitreal bevacizumab lar degeneration [AMD]), and is usually seen concurrently with AMD (3).…”

Resektion einer submakulären Traktionsmembran bei ausgeprägter Visusminderung

“…Im Rahmen des durchschnittlichen Follow-up von 37 Monaten zeigten 59 % ein Rezidiv [ 1 ]. Die PEHCR ist eine degenerative Erkrankung der Netzhaut und Aderhaut, die häufig ältere Patienten betrifft [ 2 ]. Prognostisch relevant scheinen die postoperative Integrität des retinalen Pigmentepithels nach Entfernung der Membran sowie die Genese der CNV zu sein.…”